



You are here: Home > Pharmacy News | Health Articles/Tips > Indian Drugs Approved by USFDA > September 17, 2008
India's Sun Pharma gets US FDA approval for generic of Merck's FosamaxPosted AtTradingmarkets.comMUMBAI, Sep 12, 2008 (Thomson Financial via COMTEX) - India's Sun Pharma Ltd. said it has won final approval from the U.S. Food & Drug Administration (FDA) for its generic version of Merck & Co Inc.'s osteoporosis drug Fosamax. In a statement, Sun Pharma added that Fosamax had annual sales of around $560 million in the United States. September 17, 2008
|